MAIA Biotechnology Inc
MAIA
Get informed when a big investor buys or sells
+ FollowMarket Cap$84.51M
Close$
$0.43
68% downside
Current Fair Value
68% downsideOvervalued by 68% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $84.51 Million |
|---|---|
| Enterprise Value | $56.92 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.7 |
| Beta | 0.25 |
| Outstanding Shares | 60,794,335 |
Return
| Return on Equity | -129.84% |
|---|---|
| Return on Assets | -95.06% |
| Return on Invested Capital | -126.19% |
Valuation & Multiples
| P/E Ratio | -2.19 |
|---|---|
| PEG | -4.51 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.05 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.22
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
$-0.13
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 42.11%▲ 1.16% |
|---|---|
| Total Invested | $19.44M▲ 5.62% |
| Investors Holding | 37▲ 5.00% |
ESG Score
No data